Latest filing published 01 Aug 2012 for GYRE THERAPEUTICS, INC., €264.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Steven Burrill: trading record in brief
Steven Burrill discloses dealings in 3 companies, chiefly Depomed Inc, Gyre Therapeutics, Inc. and Pharmasset Inc. We count 56 filings; the first trade dates from 5 March 2007 and the latest from 31 July 2012.
The open-market side counts 16 purchases for €1.5M alongside 8 sales for €2.6M. On balance, insiders were net sellers of €1.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants and 26 option exercises.
The median purchase comes to €2,600.
The newest entry dates from 1 August 2012: an option exercise of €264, in Gyre Therapeutics, Inc. The most recent open-market purchase was published on 1 December 2008, 6,551 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Steven Burrill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,333 shares@ US$0.075Common StockSEC:0001140361-12-034674:0
- 10,552 shares@ US$9.37Common StockSEC:0001140361-11-027143:3
- 7,500 shares@ US$9.27Common StockSEC:0001140361-11-027143:4
- 7,500 shares@ US$7.10Common StockSEC:0001140361-11-027143:5
- 7,500 shares@ US$2.71Common StockSEC:0001140361-11-027143:6
- 33,052 shares@ US$23.88Common StockSEC:0001140361-11-027143:7
- 10,000 shares@ US$5.80Common StockSEC:0001179110-11-007980:0
- 15,000 shares@ US$1.95Common StockSEC:0001179110-11-007980:1
- 15,000 shares@ US$6.76Common StockSEC:0001179110-11-007980:2
- 10,000 shares@ US$5.04Common StockSEC:0001179110-11-007980:3
- 10,000 shares@ US$6.18Common StockSEC:0001179110-11-007980:4
- 2,000 shares@ US$6.20Common StockSEC:0001179110-11-007980:5
- 87,000 shares@ US$8.25Common StockSEC:0001179110-11-007980:6
- 3,000 shares@ US$6.20Common StockSEC:0001179110-11-007980:7
- 15,000 shares@ US$3.28common StockSEC:0001179110-11-007980:8
- 15,000 shares@ US$3.27Common StockSEC:0001179110-11-007980:9
- 15,000 shares@ US$1.49Common StockSEC:0001179110-11-007980:10
- 15,000 shares@ US$3.45Common StockSEC:0001179110-11-007980:11
- 6,250 shares@ US$5.60Common StockSEC:0001179110-11-007980:12
- 69,250 shares@ US$8.09Common StockSEC:0001179110-11-007980:13
- 16,948 shares@ US$9.37Common StockSEC:0001140361-11-027096:0
- 16,948 shares@ US$24.04Common StockSEC:0001140361-11-027096:1
- 2,000 shares@ US$24.13Common StockSEC:0001140361-11-027096:2
- 10,552 shares@ US$9.37Common StockSEC:0001140361-11-027096:3
- 7,500 shares@ US$9.27Common StockSEC:0001140361-11-027096:4
25 of 53 declarations
